Business
Vivos Therapeutics to Present at March 2022 World Sleep Congress in Rome
Vivos Medical Advisory Board to Expound on Clinical Data Set of Improved Patient Outcomes at One of the World’s Largest Sleep Conferences HIGHLANDS RANCH,
About this update from Vivos Therapeutics, Inc.
[{"type":"text","content":"Vivos Medical Advisory Board to Expound on Clinical Data Set of Improved Patient Outcomes at One of the World’s Largest Sleep Conferences\nHIGHLANDS RANCH, Colo., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (OSA) and snoring in adults, today announced that its Vivos Medical Advisory Board has been selected to present a retrospective review of sleep therapy data from patients treated with the Vivos Method at this year’s World Sleep Congress on March 11–16, 2022. The World Sleep Congress is one of the largest global conferences dedicated to sleep medicine research and this year’s annual meeting will be held in Rome, Italy. Dr. Seth Heckman, MD will give the presentation on March 15, 2022, to an audience of physicians, dentists, researchers, and other professionals who congregate to learn about emerging technologies and therapies within sleep medicine. “We are very pleased to accept the invitation to deliver an oral presentation at this prestigious sleep medicine conference,” said Dr. Cecilia Wu, Co-chair of the Vivos Medical Advisory Board. “Our team has been working hard to enhance and strengthen the scientific foundation underlying Vivos’ technology, and our presentation at the World Sleep Congress is just the beginning of our scientific output.” CEO of Vivos, Kirk Huntsman, adds, “We believe that the Vivos Method, a nonsurgical way to expand and open the airway, should be offered to every individual suffering from obstructive sleep apnea. Our dental appliance is comfortable, removable, and only worn in the evening and during sleep. This sleep-related breathing disorder has a dental-driven solution that we continue to validate with clinical trials, studies, peer-reviewed papers and medical conferences.” The Vivos Method, inclusive of the Vivos System, uses cost-effective oral appliance technology prescribed by medical professionals and trained dentists to treat dentofacial anomalies and/or mild to moderate OSA and snoring in adults. The Vivos Method represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for patients. Recently, ...